In consistency with these studies, ETP-treated and F30-HSCs exhibited higher levels of pro-inflammatory gene expression, such as IL-1β, IL-6, CXCL1 and CXCL9, as well as MMPs (for tumor metastasis) than controls (Figure 2I). The gene discussed is IL6; the disease is neoplasm.